Monthly Newsletter

Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, today announced that the management system at its Oxford, UK Headquarters has been certified to BS EN ISO 9001:2008 by the British Standards Institution (BSI), one of the world's leading certification bodies. The scope of certification includes the design and provision of OGT's CytoSure^TM, Genefficiency^TM and biomarker discovery products and services, and demonstrates the company's commitment to providing the highest quality solutions and customer service.

The ISO 9001:2008 standard promotes a process approach to quality management that focuses on fully meeting customer requirements, measuring customer satisfaction and achieving continual improvement. Dr Mike Evans, OGT's CEO, commented: "ISO 9001 certification is part of a wider programme of initiatives that we are conducting to gain independent endorsement of our methods. We recently became the first company to be named as a High-Throughput Certified Service Provider for Agilent microarrays, and these initiatives put us at the forefront of the growing genomic research and clinical diagnostic products and services markets. ISO 9001 registration underpins the commitment of our talented and experienced team to designing and providing high quality products and services."

ISO 9001:2008 certification followed an assessment by BSI, requiring on-site audit and examination of OGT's documented procedures and operations, including product design and development processes. The OGT Management System will subsequently be monitored through OGT's own internal audit procedures and by periodic surveillance audits by the certification body.

For further information on OGT's products and services, please visit www.ogt.co.uk.